Regeneron Pharmaceuticals, Inc.

NASDAQ:REGN  
492.45
-6.39 (-1.28%)
4:31:00 PM EDT: $492.00 -0.45 (-0.09%)
Products

Regeneron's Regen-Cov2 Is First Antibody Cocktail For Covid-19 To Receive FDA Emergency Use Authorization

Published: 11/22/2020 01:25 GMT
Regeneron Pharmaceuticals Inc (REGN) - Regeneron's Regen-cov2 is First Antibody Cocktail for Covid-19 to Receive FDA Emergency Use Authorization.
Regeneron Pharmaceuticals Inc - Antibody Cocktail Authorized for Recently Diagnosed, Mild to Moderate Covid-19 in High-risk Patients.